America’s leading congress for diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. Join 1500+ leaders in Boston to explore breakthroughs in multiomic data, AI, genomics, and digital health in the
Programmed at BioTechX, in alphabetical order.
The companies behind the program. Tiers as disclosed.
Selected from 3 sessions.
Artificial intelligence and machine learning are transforming drug discovery and development, from target identification and candidate screening to predictive modelling, study desi…
Background: Traditional clinical trial evaluations heavily rely on the Average Treatment Effect (ATE), a metric that can obscure substantial heterogeneity in individual patient res…
Background: Traditional clinical trial evaluations heavily rely on the Average Treatment Effect (ATE), a metric that can obscure substantial heterogeneity in individual patient res…
An audience of 21 companies, parsed from the program.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page, cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.